Metric Finance
LearnFAQ
LearnFAQ

Learn / XENE

NASDAQ: XENE

Xenon Pharmaceuticals (XENE) stock, explained like you're 5

Xenon Pharmaceuticals trades on the Nasdaq under the ticker XENE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.5 billion dollars.

Ticker
XENE
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 3.5 billion dollars

Is Xenon Pharmaceuticals a small, medium or large cap company?

No. Xenon Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.5 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Xenon Pharmaceuticals makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves XENE stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Xenon Pharmaceuticals Inc. (XENE) stock price, news, quote and history (Yahoo Finance UK)
  • Vesting adds 7,500 shares for Xenon Pharmaceuticals (XENE) CFO; direct holdings total 22,500. (Stock Titan)
  • Xenon Pharmaceuticals stock hits 52 week low at 35.04 USD (Investing.com)
  • Why This Biotech Just Erased Its One Day 50% Pop (Investor's Business Daily)
  • Is Xenon Pharmaceuticals (XENE) Undervalued On Its Epilepsy Pipeline Or Already Priced In? (Simply Wall Street)

Follow XENE in your daily brief

Each trading day at 5 PM ET we post what happened to Xenon Pharmaceuticals and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow XENE

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Xenon Pharmaceuticals stock

What does Xenon Pharmaceuticals do?

Xenon Pharmaceuticals trades on the Nasdaq under the ticker XENE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 3.5 billion dollars.

What is the ticker symbol for Xenon Pharmaceuticals?

Xenon Pharmaceuticals trades under the ticker XENE on the Nasdaq.

What is Xenon Pharmaceuticals's market cap?

Xenon Pharmaceuticals is a mid cap stock with a market cap of about 3.5 billion dollars.

How does Xenon Pharmaceuticals make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves XENE stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow XENE stock every day?

Add XENE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow XENE daily

A free brief on Xenon Pharmaceuticals and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare XENE: XENE vs NVS, XENE vs AZN, XENE vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed